ALX ONCOLOGY HOLDINGS INC Other Nonoperating Income (Expense)
ALX ONCOLOGY HOLDINGS INC (ALXO) reported Other Nonoperating Income (Expense) of -$257.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Other Income
us-gaap:OtherNonoperatingIncomeExpense · last filed 2026-08-06
- ALX ONCOLOGY HOLDINGS INC other nonoperating income (expense) for the quarter ending 2026-06-30 was -$257.00K.
- ALX ONCOLOGY HOLDINGS INC other nonoperating income (expense) for the quarter ending 2026-03-31 was $188.00K.
- ALX ONCOLOGY HOLDINGS INC other nonoperating income (expense) for the quarter ending 2025-12-31 was -$17.00K.
- ALX ONCOLOGY HOLDINGS INC other nonoperating income (expense) for the quarter ending 2025-09-30 was -$6.00K, a 300.00% decline year-over-year.
- ALX ONCOLOGY HOLDINGS INC other nonoperating income (expense) for fiscal 2025 was -$36.00K.
- ALX ONCOLOGY HOLDINGS INC other nonoperating income (expense) for fiscal 2024 was -$20.00K, a 105.14% decline from fiscal 2023.
- ALX ONCOLOGY HOLDINGS INC other nonoperating income (expense) for fiscal 2023 was $389.00K.
- ALX ONCOLOGY HOLDINGS INC other nonoperating income (expense) for fiscal 2022 was -$22.00K.
| Period end | Other Nonoperating Income (Expense) 3 month | Other Nonoperating Income (Expense) 3 month as first filed | Other Nonoperating Income (Expense) 6 month | Other Nonoperating Income (Expense) 6 month as first filed | Other Nonoperating Income (Expense) 9 month | Other Nonoperating Income (Expense) 9 month as first filed | Other Nonoperating Income (Expense) 12 month | Other Nonoperating Income (Expense) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$257.00K 10-Q · filed 2026-08-06 | -$69.00K 10-Q · filed 2026-08-06 | -$86.00K derived: sum of 3 quarters · filed 2026-08-06 | -$92.00K derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | $188.00K 10-Q · filed 2026-05-08 | $171.00K derived: sum of 2 quarters · filed 2026-05-08 | $165.00K derived: sum of 3 quarters · filed 2026-05-08 | $163.00K derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | -$17.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | -$23.00K derived: sum of 2 quarters · filed 2026-03-09 | -$25.00K derived: sum of 3 quarters · filed 2026-08-06 | -$36.00K 10-K · filed 2026-03-09 | ||||
| 2025-09-30 | -$6.00K 10-Q · filed 2025-11-07 | -$8.00K derived: sum of 2 quarters · filed 2026-08-06 | -$19.00K 10-Q · filed 2025-11-07 | -$20.00K derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | -$2.00K 10-Q · filed 2026-08-06 | -$13.00K 10-Q · filed 2026-08-06 | -$14.00K derived: sum of 3 quarters · filed 2026-08-06 | -$11.00K derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | -$11.00K 10-Q · filed 2026-05-08 | -$12.00K derived: sum of 2 quarters · filed 2026-05-08 | -$9.00K derived: sum of 3 quarters · filed 2026-05-08 | -$17.00K derived: sum of 4 quarters · filed 2026-05-08 | ||||
| 2024-12-31 | -$1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $2.00K derived: sum of 2 quarters · filed 2026-03-09 | -$6.00K derived: sum of 3 quarters · filed 2026-03-09 | -$20.00K 10-K · filed 2026-03-09 | ||||
| 2024-09-30 | $3.00K 10-Q · filed 2025-11-07 | -$5.00K derived: sum of 2 quarters · filed 2025-11-07 | -$19.00K 10-Q · filed 2025-11-07 | -$48.00K derived: sum of 4 quarters · filed 2026-03-09 | ||||
| 2024-06-30 | -$8.00K 10-Q · filed 2025-08-12 | -$22.00K 10-Q · filed 2025-08-12 | -$51.00K derived: sum of 3 quarters · filed 2026-03-09 | -$52.00K derived: sum of 4 quarters · filed 2026-03-09 | ||||
| 2024-03-31 | -$14.00K 10-Q · filed 2025-05-08 | -$43.00K derived: sum of 2 quarters · filed 2026-03-09 | -$44.00K derived: sum of 3 quarters · filed 2026-03-09 | $280.00K derived: sum of 4 quarters · filed 2026-03-09 | ||||
| 2023-12-31 | -$29.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | -$30.00K derived: sum of 2 quarters · filed 2026-03-09 | $294.00K derived: sum of 3 quarters · filed 2026-03-09 | $389.00K 10-K · filed 2026-03-09 | ||||
| 2023-09-30 | -$1.00K 10-Q · filed 2024-11-07 | $323.00K derived: sum of 2 quarters · filed 2024-11-07 | $418.00K 10-Q · filed 2024-11-07 | $416.00K derived: sum of 4 quarters · filed 2025-03-06 | ||||
| 2023-06-30 | $324.00K 10-Q · filed 2024-08-12 | $419.00K 10-Q · filed 2024-08-12 | $417.00K derived: sum of 3 quarters · filed 2025-03-06 | $410.00K derived: sum of 4 quarters · filed 2025-03-06 | ||||
| 2023-03-31 | $95.00K 10-Q · filed 2024-05-09 | $93.00K derived: sum of 2 quarters · filed 2025-03-06 | $86.00K derived: sum of 3 quarters · filed 2025-03-06 | $81.00K derived: sum of 4 quarters · filed 2025-03-06 | ||||
| 2022-12-31 | -$2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | -$9.00K derived: sum of 2 quarters · filed 2025-03-06 | -$14.00K derived: sum of 3 quarters · filed 2025-03-06 | -$22.00K 10-K · filed 2025-03-06 | -$260.00K 10-K · filed 2023-03-09 | |||
| 2022-09-30 | -$7.00K 10-Q · filed 2023-11-13 | -$9.00K 10-Q · filed 2022-11-08 | -$12.00K derived: sum of 2 quarters · filed 2023-11-13 | -$20.00K 10-Q · filed 2023-11-13 | -$27.00K 10-Q · filed 2022-11-08 | -$15.00K derived: sum of 4 quarters · filed 2024-03-07 | ||
| 2022-06-30 | -$5.00K 10-Q · filed 2023-08-10 | -$7.00K 10-Q · filed 2022-08-08 | -$13.00K 10-Q · filed 2023-08-10 | -$18.00K 10-Q · filed 2022-08-08 | -$8.00K derived: sum of 3 quarters · filed 2024-03-07 | -$20.00K derived: sum of 4 quarters · filed 2024-03-07 | ||
| 2022-03-31 | -$8.00K 10-Q · filed 2023-05-11 | -$11.00K 10-Q · filed 2022-05-09 | -$3.00K derived: sum of 2 quarters · filed 2024-03-07 | -$15.00K derived: sum of 3 quarters · filed 2024-03-07 | -$13.00K derived: sum of 4 quarters · filed 2024-03-07 | |||
| 2021-12-31 | $5.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | -$7.00K derived: sum of 2 quarters · filed 2024-03-07 | -$5.00K derived: sum of 3 quarters · filed 2024-03-07 | -$7.00K 10-K · filed 2024-03-07 | $84.00K 10-K · filed 2022-02-28 | |||
| 2021-09-30 | -$12.00K 10-Q · filed 2022-11-08 | $14.00K 10-Q · filed 2021-11-12 | -$10.00K derived: sum of 2 quarters · filed 2022-11-08 | -$12.00K 10-Q · filed 2022-11-08 | $68.00K 10-Q · filed 2021-11-12 | -$942.00K derived: sum of 4 quarters · filed 2023-03-09 | ||
| 2021-06-30 | $2.00K 10-Q · filed 2022-08-08 | $28.00K 10-Q · filed 2021-08-12 | $54.00K 10-Q · filed 2021-08-12 | -$930.00K derived: sum of 3 quarters · filed 2023-03-09 | -$1.04M derived: sum of 4 quarters · filed 2023-03-09 | |||
| 2021-03-31 | -$2.00K 10-Q · filed 2022-05-09 | $26.00K 10-Q · filed 2021-05-17 | -$932.00K derived: sum of 2 quarters · filed 2023-03-09 | -$1.04M derived: sum of 3 quarters · filed 2023-03-09 | -$1.35M derived: sum of 4 quarters · filed 2023-03-09 | |||
| 2020-12-31 | -$930.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | -$1.04M derived: sum of 2 quarters · filed 2023-03-09 | -$1.35M derived: sum of 3 quarters · filed 2023-03-09 | -$1.34M 10-K · filed 2023-03-09 | -$404.00K 10-K · filed 2022-02-28 | |||
| 2020-09-30 | -$111.00K 10-Q · filed 2021-11-12 | -$416.00K derived: sum of 2 quarters · filed 2021-11-12 | -$409.00K 10-Q · filed 2021-11-12 | |||||
| 2020-06-30 | -$305.00K 10-Q · filed 2021-08-12 | -$298.00K 10-Q · filed 2021-08-12 | ||||||
| 2020-03-31 | $7.00K 10-Q · filed 2021-05-17 | |||||||
| 2019-12-31 | -$5.00K 10-K · filed 2022-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 |